DFX Intelligence
Biointel Venture Fund, L.P.
As of · the latest observation of this vehicle; each figure below carries its own filing date
FundraisingEvergreen or indefinite offeringADV: Venture Capital Fund
As of · the latest observation of this vehicle; each figure below carries its own filing date
What matters now
- +66%reported GAV
Reported gross assets rose from $91.6M to $152M between the Form ADV filings of 14 Oct 2024 and 24 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Drawing the relationship network…
Amounts, each with its basis
- Vintage
- 2024basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- indefinitewhat may be sold, not what was raised; file 021-521239, sworn by the adviser or filed under this vehicle
- Form D sold
- $111Mas of the filing of Aug 12, 2025, 28 investors
- First sale
- Aug 16, 2024
- Reported GAV
- $152Mon the Form ADV filed Mar 24, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 36
- Reported on ADV
- Oct 14, 2024 to Mar 24, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Evergreen or indefinite offering
Form D filed or amended 2025-08-12: offering indefinite, sold $110.9M (fr-1)
evidence dated Aug 12, 2025.
Lifecycle
Fundraising
Lifecycle
Form D within 18 months and the offering is not sold out
first sale: Aug 16, 2024vintage year: 2024adv gav as of: Mar 24, 2026vintage basis: Form d first saleform d sold: $111Mform d offering: n/aform d latest filed at: Aug 12, 2025
The fund's own reporting through time
2 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Oct 14, 2024 | Venture Capital Fund | $91.6M | 15 | $10.0M | 16% | yes | |
| Mar 24, 2026 | Venture Capital Fund | $152M | 36 | $10.0M | 10% |
Principals and agents
3 principals on Form D, 0 placement agents
- BioIntel Venture Partners, L.P. Director
- BioIntel Venture Partners GP, LLC Director
- Boris Nikolic Executive Officer
Service providers
3 named on Form ADV Schedule D and Form D
- AuditorFrank, Rimerman + Co. · PALO ALTO, California, United StatesForm ADV filed Mar 24, 2026 reports.adviserinfo.sec.gov
- AdministratorStandish Management · SEATTLE, Washington, United StatesForm ADV filed Mar 24, 2026 reports.adviserinfo.sec.gov
- CustodianUBS AG · NEW YORK, New York, United StatesForm ADV filed Mar 24, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
4 events
- Mar 24, 2026Auditor changed: Frank, Rimerman + Co. replaced BDO, first reported on the Form ADV filed March 24, 2026 (previous filing April 30, 2025)Auditor changed Fact Form ADV
- Aug 12, 2025BioIntel Venture Fund, L.P. filed Form D/A: $110,900,000 sold (indefinite offering), Private Equity FundForm D filed Fact Form D
- Oct 14, 2024Biointel Venture Fund, L.P. first reported on Form ADV by Biointel Venture Management, LP (Venture Capital Fund), GAV $91,600,000Fund first reported on Form ADV Fact Form ADV
- Aug 12, 2024BioIntel Venture Fund, L.P. filed Form D: no sales yet (indefinite offering), Private Equity FundForm D filed Fact Form D
Evidence
31 observations
Every observation on this vehicle
- Entity type: Limited Partnership Aug 12, 2025 Fact Form D
- Entity type: Limited Partnership Aug 12, 2024 Fact Form D
- Form D fund type: Private Equity Fund Aug 12, 2025 Fact Form D
- Form D fund type: Private Equity Fund Aug 12, 2024 Fact Form D
- Form D industry group: Pooled Investment Fund Aug 12, 2025 Fact Form D
- Form D industry group: Pooled Investment Fund Aug 12, 2024 Fact Form D
- Amendment: true Aug 12, 2025 Fact Form D
- Amendment: false Aug 12, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Aug 12, 2025 Fact Form D
- Revenue range (Form D): Not Applicable Aug 12, 2024 Fact Form D
- Incorporated: withinFiveYears Aug 12, 2025 Fact Form D
- Incorporated: withinFiveYears Aug 12, 2024 Fact Form D
- Jurisdiction: Delaware Aug 12, 2025 Fact Form D
- Jurisdiction: Delaware Aug 12, 2024 Fact Form D
- Amount sold (Form D): $111M Aug 12, 2025 Fact Form D
- Amount sold (Form D): $0 Aug 12, 2024 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Aug 12, 2025 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Aug 12, 2024 Fact Form D
- First sale: 2024-08-16 Aug 12, 2025 Fact Form D
- Indefinite offering: true Aug 12, 2025 Fact Form D
- Indefinite offering: true Aug 12, 2024 Fact Form D
- Investors (Form D): 28 Aug 12, 2025 Fact Form D
- Investors (Form D): 0 Aug 12, 2024 Fact Form D
- Minimum investment (Form D): 100,000 Aug 12, 2025 Fact Form D
- Minimum investment (Form D): 0 Aug 12, 2024 Fact Form D
- Securities offered: pooled Aug 12, 2025 Fact Form D
- Securities offered: pooled Aug 12, 2024 Fact Form D
- Office address: Aug 12, 2025 Fact Form D
- Office address: Aug 12, 2024 Fact Form D
- Year of incorporation: 2024 Aug 12, 2025 Fact Form D
- Year of incorporation: 2024 Aug 12, 2024 Fact Form D
Relationships across DFX
on 2 other DFX graphs
Across the graphs
Biointel Venture Fund, L.P. is the same institution as 2 records in RIA and Wealth and Private Equity.
RIA and Wealth1Private Equity1
DFX found 2 relationships across 2 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…
Record history
1 identity change, 3 dated events on the change ledger, latest event first
- Event retracted2026-10-01
- Form D filed2025-08-12source on record
- Fund first reported on ADV2024-10-14source on record
+1 more change on this record's ledger
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.